Rhealyn Ilagan Oira is a Chula Vista, California based counselor who is specialized as Professional Counselor. Active license number of Rhealyn Ilagan Oira is 759988 for Professional Counselor in California. Her current practice location is 835 3rd Ave Ste C, Chula Vista. Patients can book an appointment with her at 619-427-4661.
Rhealyn Ilagan Oira is a licensed mental health practitioner trained to help individuals, couples, and groups address emotional, psychological, and behavioral challenges. She uses talk therapy and evidence-based counseling methods to support clients in managing mental health conditions, improving relationships, and developing coping strategies for life’s difficulties.
Complete Profile:
Rhealyn Ilagan Oira speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1255654695
NPI Enumeration Date:
11 Mar, 2010
NPI Last Update On:
11 Mar, 2010
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Rhealyn Ilagan Oira are as mentioned below.
License Number
Specialization
State
Status
759988
Professional Counselor
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
835 3rd Ave Ste C, Chula Vista, California
Zip:
91911-1352
Phone Number:
619-427-4661
Patients can reach Rhealyn Ilagan Oira at 835 3rd Ave Ste C, Chula Vista, California or can call to book an appointment on 619-427-4661. *Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.